433 results on '"Foeldvari, I."'
Search Results
2. Application of CRISS score, revised CRISS score and RCID score in patients with Juvenile systemic sclerosis
3. Entwicklung und psychometrische Validierung eines Selbsterhebungs-Instrumentes zur übergreifenden Erfassung von Kompetenzen, ungedeckten Bedarfen und der Zufriedenheit im Transitionsprozess
4. Versorgungssituation junger Rheumatiker mit chronischen Arthritiden - eine bevölkerungsbezogene Umfrage
5. 24-Monats-Daten zu Wirksamkeit und Sicherheit von Tocilizumab im Vergleich zu TNF Inhibitoren bei polyartikulärer juveniler idiopathischer Arthritis
6. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 24 months observation period in the juvenile systemic scleroderma inception cohort
7. Elternberichtete-Outcomes und Therapiezufriedenheit im ersten Behandlungsjahr bei JIA, SLE und JDM - Interimsergebnisse aus ProKind-Rheuma
8. Langzeitwirksamkeit von Canakinumab bei autoinflammatorischen periodischen Syndromen - Interimsanalyse des RELIANCE-Registers
9. Führt die Langzeitbehandlung mit Canakinumab bei autoinflammatorischen periodischen Fiebersyndromen vermehrt zu Infektionen? 48-Monats-Daten des RELIANCE-Registers
10. Diffuse juvenile systemic sclerosis patients show distinct organ involvement, antibody pattern and have significantly more severe disease in the largest jSSc cohort of the world. Results from the juvenile scleroderma inception cohort
11. Is decreased body mass index-2 z score or less correlating with an organ involvement pattern? Results from the juvenile scleroderma inception cohort
12. Auswirkungen der Coronavirus-Pandemie auf Patienten mit autoinflammatorischen periodischen Syndromen unter Canakinumab-Behandlung - Interimsergebnisse aus dem RELIANCE-Register
13. Prävalenz und Korrelate von Angst- und Depressionssymptomen bei Jugendlichen und jungen Erwachsenen mit juveniler idiopathischer Arthritis (JIA): Ergebnisse aus COACH
14. Off-label is not always off-evidence: authorising paediatric indications for old medicines.
15. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest jSSc cohort of the world. Results from the the juvenile scleroderma inception cohort
16. Depressive und ängstliche Symptome bei Patienten mit juveniler idiopathischer Arthritis (JIA) - Daten aus der Inzeptionskohorte neu diagnostizierter Kinder und Jugendlicher mit JIA (ICON)
17. Juvenile systemic sclerosis treatment practices in an international cohort and comparison to recent SHARE consensus guidelines
18. Behandlung und Outcomes neu diagnostizierter Patient:innen mit polyartikulärer juveniler idiopathischer Arthritis (pJIA) - erste Ergebnisse aus ProKind-Rheuma
19. Wirksamkeit und Sicherheit von IL-6-Inhibition (Tocilizumab) im Vergleich zu TNF-Inhibition bei polyartikulärer juveniler idiopathischer Arthritis: Ergebnisse aus dem BIKER-Register
20. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 12 months observation period in the juvenile systemic scleroderma inception cohort
21. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from EUSTAR. Are these differences suggesting risk for mortality?
22. Occurrenceof arthritis is in 37%of the patients without overlying skin involvementinjuvenile localized scleroderma. Summary of the extracutaneous involvement in a monocentric cohort
23. Verlauf der Uveitis bei Kindern mit juveniler idiopathischer Arthritis: Daten aus der Inzeptionskohorte ICON-JIA
24. Impfsicherheit unter Canakinumab bei Patienten mit autoinflammatorischen periodischen Syndromen - Interimsanalyse des RELIANCE-Registers
25. Gesundheitsbezogene Transitionskompetenz bei Jugendlichen und jungen Erwachsenen mit juveniler idiopathischer Arthritis (JIA)
26. Langzeitsicherheit und Wirksamkeit von Canakinumab bei Cryopyrin-assoziierten periodischen Syndromen (CAPS) - 36-Monats-Daten aus dem RELIANCE-Register
27. Langzeitwirksamkeit und Sicherheit von Canakinumab bei Patienten mit familiärem Mittelmeerfieber (FMF) - Zwischenanalyse des RELIANCE-Registers
28. A STANDARDIZED ASSESSMENT OF TREATMENT AND OUTCOME OF NEWLY DIAGNOSED PATIENTS WITH JIA WITHIN THE PROKIND PROJECT - PATHWAYS FOR POLYARTICULAR JIA
29. TRANSITION COMPETENCE IN YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS HAS IMPROVED OVER TIME
30. EFFECTIVENESS AND SAFETY OF IL-6 INHIBITION (TOCILIZUMAB) VERSUS TUMOUR NECROSIS FACTOR INHIBITION IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE OBSERVATIONAL BIKER STUDY
31. New and updated recommendations for the treatment of juvenile idiopathic arthritis associated uveitis and idiopathic chronic anterior uveitis
32. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
33. Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
34. Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. Results from thejuvenile systemic sclerosis inception cohort
35. Langzeitsicherheit und -wirksamkeit von Canakinumab bei Cryopyrin-assoziierten periodischen Syndromen (CAPS) - 30-Monatsdaten des RELIANCE-Registers
36. Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com
37. Consensus-based recommendations for the management of juvenile systemic sclerosis
38. Patients with Juvenile Systemic Sclerosis Have a Distinct Pattern of Organ Involvement: Results from the Juvenile Systemic Sclerosis Inception Cohort
39. EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)
40. Male Juvenile Systemic Sclerosis Patients Have More Severe Disease: Results from the International Juvenile Scleroderma Inception Cohort
41. Juvenile systemic sclerosis (jSSc) patients with overlap characteristics do not have mild disease.Results from thejSSc inception cohort
42. COMPARISON OF THREE DIFFERENT ALGORITHMS FOR THE TREATMENT OF CHILDREN WITH POLYARTICULAR JIA: THE FIRST YEAR AFTER DIAGNOSIS
43. Langzeitwirksamkeit und -sicherheit von Canakinumab bei Patienten mit Familiärem Mittelmeerfieber (FMF) - Interimsanalyse des RELIANCE-Registers
44. Under detection of interstitial lung disease in juvenile systemic sclerosis (jSSc)
45. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
46. HEALTH RISK BEHAVIORS IN ADOLESCENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN THE COURSE OF DISEASE: RESULTS OF THE GERMAN MULTICENTER INCEPTION COHORT (ICON)
47. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
48. Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
49. JIA affected sibling pairs present high correlation for ANA and ILAR category
50. The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.